Shulman ST. Clemens von Pirquet: A Remarkable Life and Career. J Pediatric Infect Dis Soc. 2016 Oct 28. [QxMD MEDLINE Link].
Mannik M. Serum sickness and pathophysiology of immune complexes. Rich RR, ed. Clinical Immunology Principles and Practice. St. Louis, Mo: Mosby; 1996. 1062-71.
Torres MJ, Salas M, Ariza A, Fernández TD. Understanding the mechanisms in accelerated drug reactions. Curr Opin Allergy Clin Immunol. 2016 Aug. 16 (4):308-14. [QxMD MEDLINE Link].
Rixe N, Tavarez MM. Serum Sickness. Ann Allergy. 2022 Jan. 56(2):105-9. [QxMD MEDLINE Link]. [Full Text].
Frank MM, Hester CG. Immune Complex–Mediated Diseases. Adkinson NF Jr, Bochner BS, Burks W, et al, Eds. Middleton's Allergy Principles and Practice. 8th ed. Philadelphia PA: Saunders; 2014. 602-16.
Dixon FJ, Cochrane CC. Immune complex injury. Samter M, ed. Immunological Diseases. 4th ed. New York, NY: Little, Brown and Company; 1988. 233.
Pichler WJ. Drug hypersensitivity. Rich RR, ed. Clinical Immunology Principles and Practice. 4th ed. St Louis, Mo: Elsevier/Saunders; 2013. 564-77.
Sicherer SH, Leung DYM. Serum sickness. Kliegman, ed. Nelson Textbook of Pediatrics. 18th ed. Online Edition, Chapter 149.
Bayer G, Agier MS, Lioger B, Lepelley M, Zenut M, Lanoue MC, et al. Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study. Eur J Intern Med. 2019 Sep. 67:59-64. [QxMD MEDLINE Link].
Ryan NM, Kearney RT, Brown SG, Isbister GK. Incidence of serum sickness after the administration of Australian snake antivenom (ASP-22). Clin Toxicol (Phila). 2016. 54 (1):27-33. [QxMD MEDLINE Link].
Lawley TJ, Bielory L, Gascon P, Yancey KB, Young NS, Frank MM. A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med. 1984 Nov 29. 311(22):1407-13. [QxMD MEDLINE Link].
Benson E. Bupropion-induced hypersensitivity reactions. Med J Aust. 2001 Jun 18. 174(12):650-1. [QxMD MEDLINE Link].
Wooltorton E. Bupropion (Zyban, Wellbutrin SR): reports of deaths, seizures, serum sickness. CMAJ. 2002 Jan 8. 166(1):68. [QxMD MEDLINE Link]. [Full Text].
Tan MG, Burns BF, Glassman SJ. Serum sickness-like reaction associated with mirabegron. JAAD Case Rep. 2019 Jun. 5 (6):537-539. [QxMD MEDLINE Link]. [Full Text].
Gamarra RM, McGraw SD, Drelichman VS, Maas LC. Serum sickness-like reactions in patients receiving intravenous infliximab. J Emerg Med. 2006 Jan. 30(1):41-4. [QxMD MEDLINE Link].
Vermeire S, Van Assche G, Rutgeerts P. Serum sickness, encephalitis and other complications of anti-cytokine therapy. Best Pract Res Clin Gastroenterol. 2009. 23(1):101-12. [QxMD MEDLINE Link].
Pilette C, Coppens N, Houssiau FA, Rodenstein DO. Severe serum sickness-like syndrome after omalizumab therapy for asthma. J Allergy Clin Immunol. 2007 Oct. 120(4):972-3. [QxMD MEDLINE Link].
Disperati P, Hicks LK, Buckstein R. Rituximab-induced serum sickness in a patient with follicular lymphoma. Leuk Lymphoma. 2007 Aug. 48(8):1633-5. [QxMD MEDLINE Link].
Harrison RG, MacRae M, Karsh J, Santucci S, Yang WH. Anaphylaxis and serum sickness in patients receiving omalizumab: reviewing the data in light of clinical experience. Ann Allergy Asthma Immunol. 2015 Jul. 115 (1):77-8. [QxMD MEDLINE Link].
Eapen A, Kloepfer KM. Serum sickness-like reaction in a pediatric patient using omalizumab for chronic spontaneous urticaria. Pediatr Allergy Immunol. 2018 Jun. 29 (4):449-450. [QxMD MEDLINE Link].
Karmacharya P, Poudel DR, Pathak R, Donato AA, Ghimire S, Giri S, et al. Rituximab-induced serum sickness: A systematic review. Semin Arthritis Rheum. 2015 Dec. 45 (3):334-40. [QxMD MEDLINE Link].
Khan DA. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist. Ann Allergy Asthma Immunol. 2016 Aug. 117 (2):115-20. [QxMD MEDLINE Link].
Cheong J, Ooi K. Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy. Clin Kidney J. 2018 Feb. 11 (1):51-53. [QxMD MEDLINE Link]. [Full Text].
Moreira Ferreira VF, Kimbrough DJ, Stankiewicz JM. A possible case of serum sickness after ocrelizumab infusion. Mult Scler. 2021 Jan. 27 (1):155-158. [QxMD MEDLINE Link]. [Full Text].
Al-Araji S, Ciccarelli O. A possible case of serum sickness after ocrelizumab infusion - Commentary. Mult Scler. 2021 Jan. 27 (1):158-159. [QxMD MEDLINE Link]. [Full Text].
Lazoglu AH, Boglioli LR, Taff ML, Rosenbluth M, Macris NT. Serum sickness reaction following multiple insect stings. Ann Allergy Asthma Immunol. 1995 Dec. 75(6 Pt 1):522-4. [QxMD MEDLINE Link].
King BA, Geelhoed GC. Adverse skin and joint reactions associated with oral antibiotics in children: the role of cefaclor in serum sickness-like reactions. J Paediatr Child Health. 2003 Dec. 39(9):677-81. [QxMD MEDLINE Link].
Karliner JS, Belaval GS. Incidence of reactions following administration of antirabies serum; study of 526 cases. JAMA. 1965 Aug 2. 193:359-62. [QxMD MEDLINE Link].
Fajt ML, Petrov AA. Desensitization protocol for rituximab-induced serum sickness. Curr Drug Saf. 2014. 9(3):240-2. [QxMD MEDLINE Link].
Dilley MA, Lee JP, Platt CD, Broyles AD. Rituximab Desensitization in Pediatric Patients: Results of a Case Series. Pediatr Allergy Immunol Pulmonol. 2016 Jun 1. 29 (2):91-94. [QxMD MEDLINE Link]. [Full Text].
Abraham E, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA. 1995 Mar 22-29. 273(12):934-41. [QxMD MEDLINE Link].

Media Gallery

A 29-year-old woman with RA presented with fever, a diffuse skin rash, and arthralgia approximately 10 days after receiving intravenous rituximab. Diagnosis was rituximab-associated serum sickness. Image courtesy of Jason Kolfenbach, MD, and Kevin Deane, MD, Division of Rheumatology, University of Colorado Denver School of Medicine.

of 1

Author

Hassan M Alissa, MD Rheumatologist, Multispecialty Group, San Marcos, Texas

Hassan M Alissa, MD is a member of the following medical societies: American College of Rheumatology

Disclosure: Nothing to disclose.

Coauthor(s)

Susan M Chen, MD Clinical Assistant Professor, Department of Emergency Medicine, University of Pennsylvania Health System, Penn Presbyterian Medical Center

Susan M Chen, MD is a member of the following medical societies: American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

Francis Counselman, MD, FACEP Chair, Professor, Department of Emergency Medicine, Eastern Virginia Medical School

Francis Counselman, MD, FACEP is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, Norfolk Academy of Medicine, Association of Academic Chairs of Emergency Medicine, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Elaine Adams, MD Associate Chief of Staff, Chief of Rheumatology Section, Hines Veterans Affairs Hospital; Professor of Medicine, Loyola University School of Medicine

Elaine Adams, MD is a member of the following medical societies: American College of Physicians, American College of Rheumatology

Disclosure: Nothing to disclose.

Rochella Abaygar Ostrowski, MD Assistant Professor, Department of Medicine, Division of Rheumatology, Loyola University Medical Center; Staff Physician, Department of Medicine, Division of Rheumatology, Edward Hines Jr Veterans Affairs Hospital

Rochella Abaygar Ostrowski, MD is a member of the following medical societies: American College of Physicians, American College of Rheumatology

Disclosure: Nothing to disclose.

Richard Hariman, MD Assistant Professor, Division of Rheumatology, Medical College of Wisconsin

Richard Hariman, MD is a member of the following medical societies: American College of Rheumatology

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Elliot Goldberg, MD Dean of the Western Pennsylvania Clinical Campus, Professor, Department of Medicine, Lewis Katz School of Medicine at Temple University

Elliot Goldberg, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American College of Rheumatology

Disclosure: Nothing to disclose.

Chief Editor

Herbert S Diamond, MD Visiting Professor of Medicine, Division of Rheumatology, State University of New York Downstate Medical Center; Chairman Emeritus, Department of Internal Medicine, Western Pennsylvania Hospital

Herbert S Diamond, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American College of Rheumatology, American Medical Association, Phi Beta Kappa

Disclosure: Nothing to disclose.

Additional Contributors

Matthew M Rice, MD, JD, FACEP Senior Vice President, Chief Medical Officer, Northwest Emergency Physicians of TeamHealth; Assistant Clinical Professor of Medicine, University of Washington School of Medicine Pending Approval

Matthew M Rice, MD, JD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, National Association of EMS Physicians, Society for Academic Emergency Medicine, Washington State Medical Association

Disclosure: Nothing to disclose.

Serum Sickness Questions & Answers

References

Tables

Contributor Information and Disclosures

What would you like to print?